PURE: The burden and long-term outcomes of diagnosed and underdiagnosed COPD across diverse communities from high-income, middle-income, and low-income countries

The Lancet Global Health

Duong M, Kang E, Rangarajan S, Ramacham Parambath S, Rosengren A, Nair S, Lanas F, Ma X, Liu Z, Ah Tse L, Mony PK, Mir H, Abat MEM, Lakshmi PVM, Alhabib KF, Assembekov B, Avezum A, Bahonar A, Barbarash O, Chifamba J, Luz Diaz M, Erkin M, Felix C, Iqbal R, Khatib R, Lopez-Jaramillo P, Mat-Nasir N, Oguz A, Swart EC, Yeates K, Yusuf R, Yusufali A, Zatońska K, Teo KK, Yusuf S, PURE investigators.

October 2026

Read More

OCEANIC-STROKE: Bleeding With Asundexian Versus Placebo in Patients With Noncardioembolic Ischemic Stroke or High-Risk TIA

Circulation

Eikelboom JW, Xu L, Shoamanesh A, Dong Q, Hirano T, Saver JL, Masjuan J, Demchuk AM, Cordonnier C, Bereczki D, Tsivgoulis G, Veltkamp R, Staikov I, Bae HJ, Campbell BCV, Zini A, Lee IH, Kovář M, Mikulik R, Lemmens R, Ferro JM, Robinson T, Christensen H, Ozturk S, Leker RR, Turcani P, Slowik A, Amaya P, Hoo FK, De Marchis GM, Knoflach M, Sylaja PN, Putaala J, Coutinho JM, van der Worp HB, Miglane E, Matijošaitis V, Lindgren AG, Silva GS, Sandset EC, Turuspekova ST, Colorado P, Kasner SE, Keller L, Neumann C, Muehlhofer E, Iversen HK, Silva Y, Ayo-Martín O, Shuaib A, Wang Z, Schulze K, Joundi RA, Sharma M.

October 2026

Read More

ANNEXa-I: Non-contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: An Analysis from ANNEXa-I Trial.

Annals of Neurology

Tanaka K, Pensato U, Alshamrani M, Katsanos AH, Balali P, Ray S, Kasner SE, Beyer-Westendorf J, Toni D, Seiffge DJ, Molina C, Tanne D, Członkowska A, Lindgren AG, Bereczki D, Sandset EC, Tsivgoulis G, Christensen H, Coutinho JM, Verhamme P, Amarenco P, Lemmens R, Veltkamp R, Middeldorp S, Robinson T, Milling TJ, Lang W, Tedium-Cruz V, Crowther M, Xu L, Knutsson M, Ladenvall P, Eikelboom JW, Sharma M, Shoamanesh A, Demchuk AM.

September 2026

Read More

COP-AF: Colchicine to prevent cardiovascular events in thoracic surgery patients with or without coronary artery disease: a secondary analysis

Open Heart

Razeghi G, Wang MK, Devereaux PJ, Popova E, Chan MT, Sessler DI, Landoni G, Warwas M, McIntyre WF, Ofori S, Balasubramanian K, Tandon V, Finley CJ, Shanthanna H, Tallada AG, Cata JP, Choi EK, Shah SU, Srinathan SK, Reimer C, McLean SR, Trujillo JC, Fleischmann E, Kabon B, Voltolini L, Cruz P, Maziak DE, Gutiérrez-Soriano L, Sigamani A, Amir M, Conen D; COP-AF investigators

September 2026

Read More

Back To Top